175 related articles for article (PubMed ID: 18279516)
1. Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model.
Woditschka S; Haag JD; Mau B; Lubet RA; Gould MN
Breast Cancer Res; 2008; 10(1):R18. PubMed ID: 18279516
[TBL] [Abstract][Full Text] [Related]
2. A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.
Woditschka S; Haag JD; Sullivan R; Gould MN
Cancer Prev Res (Phila); 2009 Feb; 2(2):153-60. PubMed ID: 19196722
[TBL] [Abstract][Full Text] [Related]
3. Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas.
Woditschka S; Haag JD; Waller JL; Monson DM; Hitt AA; Brose HL; Hu R; Zheng Y; Watson PA; Kim K; Lindstrom MJ; Mau B; Steele VE; Lubet RA; Gould MN
Cancer Res; 2006 Jul; 66(13):6884-91. PubMed ID: 16818667
[TBL] [Abstract][Full Text] [Related]
4. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.
Kisková T; Jendželovský R; Rentsen E; Maier-Salamon A; Kokošová N; Papčová Z; Mikeš J; Orendáš P; Bojková B; Kubatka P; Svoboda M; Kajo K; Fedoročko P; Jäger W; Ekmekcioglu C; Kassayová M; Thalhammer T
Eur J Cancer Prev; 2014 Nov; 23(6):506-13. PubMed ID: 25254309
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris RE; Alshafie GA; Abou-Issa H; Seibert K
Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
[TBL] [Abstract][Full Text] [Related]
8. Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis.
Negi AK; Kansal S; Bhatnagar A; Agnihotri N
Tumour Biol; 2013 Dec; 34(6):3753-64. PubMed ID: 24057882
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
10. Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.
Sereno J; Parada B; Reis F; Cunha FX; Teixeira-Lemos E; Garrido P; Pinto R; Rocha-Pereira P; Neto P; Ruivo J; Rodrigues-Santos P; Nunes S; Mota A; Figueiredo A; Teixeira F
Mediators Inflamm; 2010; 2010():380937. PubMed ID: 21403827
[TBL] [Abstract][Full Text] [Related]
11. The role of COX-2 inhibition in breast cancer treatment and prevention.
Arun B; Goss P
Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice.
Wong TY; Li F; Lin SM; Chan FL; Chen S; Leung LK
BMC Cancer; 2014 Jun; 14():426. PubMed ID: 24923427
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
Badawi AF; Eldeen MB; Liu Y; Ross EA; Badr MZ
Cancer Res; 2004 Feb; 64(3):1181-9. PubMed ID: 14871855
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.
Alshafie GA; Abou-Issa HM; Seibert K; Harris RE
Oncol Rep; 2000; 7(6):1377-81. PubMed ID: 11032948
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib and melatonin in prevention of female rat mammary carcinogenesis.
Orendas P; Kassayova M; Kajo K; Ahlers I; Kubatka P; Bojkova B; Pec M; Ahlersova E
Neoplasma; 2009; 56(3):252-8. PubMed ID: 19309229
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
Howe LR; Subbaramaiah K; Patel J; Masferrer JL; Deora A; Hudis C; Thaler HT; Muller WJ; Du B; Brown AM; Dannenberg AJ
Cancer Res; 2002 Oct; 62(19):5405-7. PubMed ID: 12359744
[TBL] [Abstract][Full Text] [Related]
19. Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
Brown PH; Subbaramaiah K; Salmon AP; Baker R; Newman RA; Yang P; Zhou XK; Bissonnette RP; Dannenberg AJ; Howe LR
Cancer Prev Res (Phila); 2008 Aug; 1(3):208-14. PubMed ID: 19138958
[TBL] [Abstract][Full Text] [Related]
20. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
